© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Angiogenesis and platelets: the clot thickens further
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Dudley Road, Birmingham, B18 7QH, UK
* Tel./fax: +44-121-507-5076. Email address: a.blann@bham.ac.uk
Received 10 May 2004; accepted 14 May 2004
| The first 10% of the full text of this article appears below. |
See article by Brill et al. [15] (pages 226–235) in this issue.
Pathophysiogical aspects of platelet biology have, until recently, focussed on their relatively passive and reactive roles in minimising blood loss after injury, in contributing to the final stages of cardiovascular disease (largely in the inappropriate formation of life-threatening thrombosis), and on attempts in the clinic, the cardiac catheter suite, and on the ward to reduce the latter with anti-coagulant and anti-platelet agents. However, there is currently a growing awareness that another pathophysiological process, inflammation, may be important in atherosclerosis and acute coronary
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Choudhury, I. Chung, A. D. Blann, and G. Y.H. Lip Platelet Surface CD62P and CD63, Mean Platelet Volume, and Soluble/Platelet P-Selectin as Indexes of Platelet Function in Atrial Fibrillation: A Comparison of "Healthy Control Subjects" and "Disease Control Subjects" in Sinus Rhythm J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1957 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Lee, G. Y.H. Lip, and A. D. Blann Plasma Angiopoietin-1, Angiopoietin-2, Angiopoietin Receptor Tie-2, and Vascular Endothelial Growth Factor Levels in Acute Coronary Syndromes Circulation, October 19, 2004; 110(16): 2355 - 2360. [Abstract] [Full Text] [PDF] |
||||

